The Leadership Team at BridgeBio Oncology Therapeutics is responsible for guiding the strategic direction of the company, ensuring effective drug development and clinical progression of novel therapies targeting RAS and PI3K-driven cancers. This team collaborates across functional areas, including drug discovery, clinical development, and operations, to drive innovation and optimize patient outcomes while managing resources and stakeholder relationships.